Search results for:
Cefdinir
cefdinir
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Omnicef |
CAPSULE, ORAL |
300 mg |
|
|
|
|
| Omnicef |
POWDER FOR RECONSTITUTION, ORAL |
125 mg/5 mL, 250 mg/5 mL |
|
|
|
|
Last updated: Aug. 28, 2026
Non-Formulary. Preferred alternatives provide superior pharmacokinetics, broader antimicrobial coverage, lower cost, and better clinical outcomes. Alternative agents (not all inclusive) include amoxicillin, amoxicillin/clavulanate, or cefpodoxime (for patients with true penicillin allergy).
FOR PEDIATRICS
All orders for oral 2nd or 3rd generation cephalosporins should be interchanged to cefpodoxime at an equivalent / appropriate weight-based dose.
Reviewed: July 24, 2012 (pediatric use)
Updated: September 25, 2012 (adult use), 24 May 2016 , August 2026 (formulary removal)